loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Drug Master Files (DMF) for 5756 Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Heumann

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PharmaCompass

    Inke S.A: APIs manufacturing plant.

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Heumann (1)

    filter

    01 METOCLOPRAMIDE HCL. (1)

    filter

    01 Germany (1)

    filter

    01 Inactive (1)

    filter

    01 Blank (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    LUDWIG HEUMANN AND CO GMBH

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag Germany
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      METOCLOPRAMIDE HCL.

      PDF Supplier PDF
      URL Supplier Web Content
      5756
      Inactive
      1985-03-29
      N/A
      II
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for Drug Master Files (DMF) for 5756 of Ludwig Heumann And Co Gmbh

      Looking for Drug Master Files (DMF) for 5756 of Ludwig Heumann And Co Gmbh 1

      20

      Ludwig Heumann And Co Gmbh, based in Germany, is a pharmaceutical company.

      One of their notable products is METOCLOPRAMIDE HCL., with a corresponding US DMF Number 5756.

      Remarkably, this DMF maintains an Inactive status since its submission on March 29, 1985, highlighting commitment to regulatory compliance.

      Post Enquiry
      POST ENQUIRY